ABUS icon

Arbutus Biopharma

49 hedge funds and large institutions have $65.5M invested in Arbutus Biopharma in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 18 closing their positions.

Holders
49
Holders Change
+1
Holders Change %
+2.08%
% of All Funds
1.31%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
21
Increased
15
Reduced
10
Closed
18
Calls
$8.69M
Puts
$3.66M
Net Calls
+$5.03M
Net Calls Change
+$12.5M
Name Market Value Shares Shares
Change
Shares
Change %
Tudor Investment Corp
51
Tudor Investment Corp
Connecticut
-100,000 Closed
ARTA
52
A.R.T. Advisors
New York
-66,583 Closed
Jane Street
53
Jane Street
New York
-54,179 Closed
BlackRock
54
BlackRock
New York
-53,800 Closed
EGM
55
Espalier Global Management
New York
-50,000 Closed
VKH
56
Virtu KCG Holdings
New York
-44,629 Closed
BIM
57
BlackRock Investment Management
Delaware
-24,000 Closed
LP
58
LMR Partners
United Kingdom
-15,895 Closed
CA
59
Commerzbank Aktiengesellschaft
Germany
-14,100 Closed
Millennium Management
60
Millennium Management
New York
-12,600 Closed
PC
61
Polar Capital
United Kingdom
-11,299 Closed
FAAS
62
First Allied Advisory Services
California
-11,200 Closed
Goldman Sachs
63
Goldman Sachs
New York
-9,512 Closed
QT
64
Quantbot Technologies
New York
-7,432 Closed
ST
65
Spot Trading
Illinois
-742 Closed
First Manhattan
66
First Manhattan
New York
-100 Closed
SM
67
Sabby Management
Florida
JT
68
Jump Trading
Illinois
WMSA
69
Weiss Multi-Strategy Advisers
New York
Simplex Trading
70
Simplex Trading
Illinois
TCP
71
Tourbillon Capital Partners
New York
PG
72
PEAK6 Group
Illinois
MAA
73
Managed Account Advisors
New Jersey
$0 9 +9 New